NCT04965844
Completed
Not Applicable
Safety and Efficacy of a Closed-loop Oxygen Control for High Flow Nasal Therapy in ICU Patients: a Randomized Cross-over Study (The HILOOP Study)
Hospital Universitari Vall d'Hebron Research Institute1 site in 1 country53 target enrollmentApril 27, 2021
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- High Flow Nasal Cannula
- Sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Enrollment
- 53
- Locations
- 1
- Primary Endpoint
- Percentage of time spent in optimal SpO2 range
- Status
- Completed
- Last Updated
- 4 years ago
Overview
Brief Summary
In patients with acute hypoxemic respiratory failure (AHRF), High Flow Nasal Therapy (HFNT) improves oxygenation, tolerance, and decrease work of breathing as compared to standard oxygen therapy by facemask. Current guidelines recommend adjusting oxygen flow rates to keep the oxygen saturation measured by pulse oximetry (SpO2) in the target range and avoid hypoxemia and hyperoxemia. The hypothesis of the study is that closed loop oxygen control increases the time spent within clinically targeted SpO2 ranges and decreases the time spent outside clinical target SpO2 ranges as compared to manual oxygen control in ICU patients treated with HFNT.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Adult (\>17yo) patients admitted to the ICU treated with HFNT for at least 8h
- •Requiring FiO2 ≥ 30% to keep SpO2 in the target ranges defined by the clinician
- •Written informed consent signed and dated by the patient or one relative in case that the patient is unable to consent, after full explanation of the study by the investigator and prior to study participation.
Exclusion Criteria
- •Patient with indication for immediate continuous positive airway pressure (CPAP), noninvasive ventilation (NIV), or invasive mechanical ventilation
- •Hemodynamic instability defined as a need of continuous infusion of epinephrine or norepinephrine \> 1 mg/h
- •Low quality on the SpO2 measurement using finger and ear sensor (quality index below 60% on the Massimo SpO2 sensor, which is displayed by a red or orange colour bar)
- •Severe acidosis (pH ≤ 7.30)
- •Pregnant woman
- •Patients deemed at high risk for need of mechanical ventilation within the next 8 hours
- •Chronic or acute dyshemoglobinemia: methemoglobin, carbon monoxide (CO) poisoning, sickle cell disease
- •Tracheotomised patient
- •Formalized ethical decision to withhold or withdraw life support
- •Patient under guardianship
Outcomes
Primary Outcomes
Percentage of time spent in optimal SpO2 range
Time Frame: 4 hours
The optimal SpO2 range will be defined according to the SpO2 targets determined by the clinician.
Secondary Outcomes
- Percentage of time spent out of range(4 hours)
- Percentage of time spent in sub-optimal SpO2 range(4 hours)
- Percentage of time with SpO2 signal available(4 hours)
- Mean SpO2/FiO2(4 hours)
- ROX index(4 hours)
- Percentage of time with SpO2 below 88 and 85 percent(4 hours)
- Number of events with SpO2 below 88 and 85 percent(4 hours)
- Mean FiO2(4 hours)
- Percentage of time with FiO2 below 40 percent and above 60%(4 hours)
- Number of manual adjustments(4 hours)
- Number of alarms(4 hours)
- Patient comfort(4 hours)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Efficiency of HFNC Vs NIV in Patient With Acute Type 2 RFType 2 Respiratory FailureNCT05698641Beni-Suef University100
Completed
Not Applicable
The Physiologic Effect of the Flow Generated by High Flow Nasal Cannula in Mild Respiratory FailureRespiratory FailureNCT05708287Hadassah Medical Organization28
Unknown
Not Applicable
High Flow Nasal Cannula Versus Non-invasive Ventilation in Prevention of Escalation to Invasive Mechanical Ventilation in Patients With Acute Hypoxemic Respiratory FailureRespiratory FailureNCT03788304Assiut University100
Completed
Not Applicable
Physiologic Effects of High Flow Nasal Therapy in Patients With Acute Hypoxemic Respiratory Failure (OPTIFLOW)Respiratory FailureNCT01056952University Hospital, Bordeaux12
Completed
Not Applicable
'Optiflow + Duet' Interface' vs 'Standard' High Flow Nasal CannulaHypoxemiaNCT05838326University of Padova20